Related Experiment Video
Updated: Aug 19, 2026
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line
Marion L Gehrmann1, Catherine Fenselau, Yetrib Hathout
1Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, USA.
Abstract:
The protein expression pattern in the cytosol fraction of the adriamycin resistant MCF-7 cell line (MCF-7/ADR) was compared to that of the parental MCF-7 cell line using two-dimensional gel electrophoresis and mass spectrometry. Twenty proteins with altered abundances were identified and studied in MCF-7/ADR. Both up regulation and down regulation are characterized. The most striking differences were found for proteins that were uniquely expressed in this cell line and not detectable in the parental MCF-7 cell line. These proteins include annexin I, the neuronal ubiquitin carboxyl hydrolase isoenzyme L-1 (also known as PGP9.5), glutathione-S-transferase pi class, nicotinamide N-methyltransferase, and interleukin-18 precursor. On the other hand, catechol-O-methyltransferase was expressed in the parental cell line, but was not detected in the adriamycin resistant cell line. This protein expression pattern was unique to MCF-7/ADR and not observed in MCF-7 cell lines selected for resistant to etoposide, mitoxantrone or melphalan.
Insights
Adriamycin-resistant MCF-7 cells exhibit unique protein expression changes, including novel annexin I and PGP9.5, not seen in other resistant cell lines. These findings offer insights into adriamycin resistance mechanisms.
Area of Science:
- Proteomics
- Cell Biology
- Cancer Research
Background:
- Adriamycin resistance in breast cancer is a significant clinical challenge.
- Understanding the molecular mechanisms of drug resistance is crucial for developing effective therapies.
- MCF-7 cells are a widely used human breast cancer cell line model.
Purpose of the Study:
- To compare the proteomic profiles of adriamycin-resistant MCF-7 cells (MCF-7/ADR) with their parental counterparts.
- To identify specific proteins associated with adriamycin resistance.
- To investigate the uniqueness of these protein alterations in MCF-7/ADR cells.
Main Methods:
- Two-dimensional gel electrophoresis (2D-PAGE) for protein separation.
- Mass spectrometry (MS) for protein identification.
- Comparative proteomic analysis of MCF-7/ADR and parental MCF-7 cell lines.
Main Results:
- Twenty proteins showed altered abundance in MCF-7/ADR cells compared to parental cells.
- Unique protein expression in MCF-7/ADR included annexin I, neuronal ubiquitin carboxyl hydrolase isoenzyme L-1 (PGP9.5), glutathione-S-transferase pi class, nicotinamide N-methyltransferase, and interleukin-18 precursor.
- Catechol-O-methyltransferase was downregulated in MCF-7/ADR cells.
- The observed protein expression pattern was specific to adriamycin resistance and not found in cells resistant to other chemotherapeutics.
Conclusions:
- MCF-7/ADR cells display a distinct proteomic signature associated with adriamycin resistance.
- Several identified proteins may play a role in the development or maintenance of adriamycin resistance.
- The unique protein profile highlights the specificity of resistance mechanisms to different chemotherapeutic agents.
